Yeongdeungpo Internal Medicine Stem Cell Therapy For Chronic Conditions Expanded

via Press Release Distribution Service
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Patients in Yeongdeungpo exploring non-invasive regenerative treatment options for chronic inflammatory and metabolic conditions can now access Lydian Cosmetic Surgery Clinic's internal medicine stem cell therapy program, following the clinic's service expansion into the district.

-- Lydian Cosmetic Surgery Clinic has expanded its internal medicine stem cell therapy services into Yeongdeungpo, giving patients access to regenerative medicine as part of individualized care plans for chronic inflammatory, digestive, metabolic, respiratory, and autoimmune conditions. The program is intended for patients seeking additional non-invasive treatment options that can be incorporated into broader medical management under clinical supervision.

More details are available at https://www.lydianclinic.com/blog/stem-cell-therapy-alzheimers-parkinsons-als/

As chronic health conditions become longer-term management challenges for many patients, interest in regenerative medicine has continued to grow alongside conventional medical care. Internal medicine focuses on diagnosing disease and managing complex health conditions, while regenerative therapies are increasingly being incorporated into treatment strategies for selected patients following clinical evaluation. Research cited by GlobalRPH.com shows that approximately 67% of patients receiving stem cell therapy report a good to excellent quality of life following treatment, with 64% describing improvements in physical health.

At Lydian Cosmetic Surgery Clinic, treatment uses high-purity mesenchymal stem cells selected for their established clinical safety profile and regenerative potential. The clinic states that all procedures follow Korean medical standards, use certified stem cell sources, and are carried out in sterile clinical environments. Depending on the patient's treatment plan, stem cells may be autologous or donor-derived mesenchymal cells.

Each treatment program begins with an individual clinical assessment that considers the patient's diagnosis, stage of disease, and overall health. Based on those findings, physicians may combine stem cell therapy with intravenous infusions, targeted delivery protocols, anti-inflammatory laser therapy, nutritional support, and other complementary approaches when appropriate as part of a coordinated care plan.

"Every patient presents with a different medical history and set of clinical needs," a spokesperson for Lydian Cosmetic Surgery Clinic said. "Our role is to evaluate each case carefully and develop a treatment strategy that reflects those individual circumstances while following established medical standards."

Led by Dr. Abraham An, Lydian Cosmetic Surgery Clinic combines regenerative medicine, internal medicine, and medical aesthetics to develop patient-specific treatment protocols. The clinic provides stem cell therapies using certified cell sources within regulated clinical settings designed to support patient safety throughout the treatment process.

Those interested can find additional information at https://www.lydianclinic.com/

Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Website: https://www.lydianclinic.com/

Source: NewsNetwork

Release ID: 89199656

If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article